Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Pacific Biosciences of California Inc PACB

Technology Scientific & Technical Instruments
Pacific Biosciences of California, Inc. is a life science technology company. It is engaged in designing, developing, and manufacturing advanced sequencing solutions that enable scientists and clinical researchers to resolve genetically complex problems. Its products and technology under development stem from two differentiated core technologies, which include its HiFi long-read sequencing... see more

Recent & Breaking News (NDAQ:PACB)

Pacific Biosciences of California, Inc. Announces Third Quarter 2016 Financial Results

GlobeNewswire November 2, 2016

PacBio Files ITC Patent Infringement Complaint Against Oxford Nanopore

GlobeNewswire November 2, 2016

Novel Human Genetics Discoveries Using PacBio Long-Read Sequencing to be Presented at ASHG Annual Meeting

GlobeNewswire October 17, 2016

Pacific Biosciences of California, Inc. Third Quarter 2016 Financial Results Call

GlobeNewswire October 13, 2016

G10K and B10K Initiatives Select PacBio SMRT Sequencing for Next Phase of Genome Projects

GlobeNewswire October 13, 2016

Cantor Cuts Illumina's Price Target To $155, Positive On Pacific Biosciences Of California

Benzinga.com  October 11, 2016

14 Stocks Moving In Tuesday's Pre-Market Session

Benzinga.com  October 11, 2016

Research Reports Initiation on Biotech Stocks -- Pacific Biosciences of California, Marinus Pharma, Emergent BioSolutions and Ampio Pharma

PR Newswire October 10, 2016

Dovetail Genomics Adds PacBio SMRT Sequencing and Assembly to Its Services Menu

PR Newswire September 22, 2016

25 Biggest Mid-Day Gainers For Friday

Benzinga.com  August 5, 2016

22 Stocks Moving In Friday's Pre-Market Session

Benzinga.com  August 5, 2016

Pacific Biosciences Releases New Software and Chemistry for Sequel System

GlobeNewswire August 4, 2016

Pacific Biosciences of California, Inc. Announces Second Quarter 2016 Financial Results

GlobeNewswire August 4, 2016

HistoGenetics Wins Multi-Year Contract for HLA Typing Using PacBio Sequencing

GlobeNewswire August 1, 2016

Pacific Biosciences of California, Inc. Second Quarter 2016 Financial Results Call

GlobeNewswire July 12, 2016

Cold Spring Harbor Laboratory Scientists Produce High-Quality Maize Transcriptome with PacBio SMRT Sequencing

GlobeNewswire June 24, 2016

Coverage of Biotechnology Equities - Pacific Biosciences of California, Peregrine Pharma, Dynavax Technologies and Anavex Life Sciences

PR Newswire June 10, 2016

Pacific Biosciences and Advanced Analytical Technologies Announce Co-Marketing Agreement

GlobeNewswire April 26, 2016

Pacific Biosciences of California, Inc. Announces First Quarter 2016 Financial Results

GlobeNewswire April 21, 2016

Pacific Biosciences of California, Inc. First Quarter 2016 Financial Results Call

GlobeNewswire April 5, 2016